Quick links

Fractured Neck of Femur (FNoF) Splint

Improving care for FNoF patients

ID3: Develop the Opportunity

To view this page ensure that Adobe Flash Player is installed.

Get Adobe Flash player

Executive Summary

Fractured Neck of Femur is a common injury encountered by Paramedics. The NHS treats over 70,000 patients with FNoF annually. This new device developed in collaboration with the NIC, Queens Medical Centre Nottingham, West Midlands Ambulance Service and Canard Design aims to reduce pain and blood loss leading to greater comfort and improved outcomes for the patient.

Quick Detail

Innovation Owner:
Peter Taylor
Development stage:
ID3: Develop the Opportunity

Project Detail

The Unmet Need

Between 2005 and 2006 the NHS operated on 68,416* patients with a fractured neck of femur costing an estimated £384 million. Older people are particularly susceptible with many suffering a FNoF following a fall. Patients experience considerable discomfort and require rapid intervention to stabilise the fracture to reduce blood loss and pain. Working closely with Paramedics and Orthopaedic specialists the NIC identified a number of unmet clinical needs relating to the current care and transportation of FNoF patients. In particular existing splinting devices and methods fail to stabilise the hip fully resulting in increased pain and blood loss. *Focus on Fractured Neck of Femur, NHS Institute for Innovation and Improvement, 2006

Proposed Solution

Following on from the identification of the unmet clinical needs a new splint has been developed through collaboration between Professor W Angus Wallace (Professor of Orthopaedic & Accident Surgery, Queens Medical Centre, Nottingham), Mr Andy Hayles (Paramedic West Midlands Ambulance Service) and a design company (Canard Design). The NIC provided funding support to develop the solution to a working prototype which is now undergoing a clinical trial. The new device stabilises the fracture by means of an articulated splint which allows the responding Paramedic to immobilise the limb there reducing pain and blood loss. Unlike other splinting devices this new device has been designed to support the patient through A&E, X-Ray and into Theatre.   

Intended Benefits

This new device has a number of intended benefits:

  1. To reduce pain and the subsequent use of analgesics (e.g. Morphine) which can have lasting impact on the patients recovery
  2. To reduce blood loss and subsequent increased risk of mortality
  3. To provide Paramedics with a device which is quick to fit therefore speeding up the patents delivery to A&E

Key Facts


  • Clinical outcomes
  • Patient experience

Healthcare Areas

  • Acute Care

Health Problems

  • Trauma and Orthopaedics
  • Musculoskeletal


  • Domestic